Real-world outcomes with ibrutinib in relapsed or refractory mantle cell lymphoma: a Danish population-based studyTrine Trab, Kirsten Grønbæk, Michael Roost Clausen et al.|Blood Neoplasia|2025Cited by 4
Real-World Outcomes for Patients Treated with Ibrutinib for Relapsed/Refractory Mantle Cell Lymphoma in DenmarkTrine Trab, Kirsten Grønbæk, Tarec Christoffer El‐Galaly et al.|Blood|2024Cited by 0